Syntax Bio
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
$14.4MSeries A+
Role not disclosedLoading investors…
Activity from announced rounds
Develops cell therapies using proprietary Cellgorithm platform for regenerative medicine
Automates disaster recovery and resilience testing for enterprises running complex cloud environments on AWS and Azure
Pitching Draper Associates? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room